IR@PKUHSC  > 北京大学第三临床医学院
学科主题临床医学
Phase II study of chidamide (CS055), a new subtype-selective oral histone deacetylase inhibitor, in patients with relapsed or refractory peripheral T-cell lymphoma
Shi, Yuan-Kai; Dong, Mei; Hong, Xiao-Nan; Zhang, Wei-Jing; Feng, Ji-Feng; Zhu, Jun; Yu, Li; Ke, Xiao-Yan; Huang, Hui-Qiang; Shen, Zhi-Xiang; Fan, Yun; Li, Wei; Zhao, Xie-Lan; Qiu, Lu-Gui; Huang, He
刊名JOURNAL OF CLINICAL ONCOLOGY
2013-05-20
suppl.S期:15
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
语种英语
WOS记录号WOS:000335419602621
引用统计
被引频次:2[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/59812
专题北京大学第三临床医学院
作者单位1.Cent S Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China
2.Peking Univ, Hosp 3, Beijing 100871, Peoples R China
3.Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
4.Jilin Univ, Hosp 1, Changchun 130023, Peoples R China
5.Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China
6.Fudan Univ, Shanghai Canc Ctr, Shanghai 200433, Peoples R China
7.PLA, Hosp 307, Beijing, Peoples R China
8.Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China
9.Beijing Canc Hosp, Beijing, Peoples R China
10.Peking Union Med Coll, Beijing 100021, Peoples R China
11.Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
12.Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China
13.Shanghai Jiao Tong Univ, Ruijin Hosp, Coll Med, Shanghai 200030, Peoples R China
14.Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China
15.Peking Union Med Coll, Tianjin, Peoples R China
16.Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China
推荐引用方式
GB/T 7714
Shi, Yuan-Kai,Dong, Mei,Hong, Xiao-Nan,et al. Phase II study of chidamide (CS055), a new subtype-selective oral histone deacetylase inhibitor, in patients with relapsed or refractory peripheral T-cell lymphoma[J]. JOURNAL OF CLINICAL ONCOLOGY,2013,suppl.S(15).
APA Shi, Yuan-Kai.,Dong, Mei.,Hong, Xiao-Nan.,Zhang, Wei-Jing.,Feng, Ji-Feng.,...&Huang, He.(2013).Phase II study of chidamide (CS055), a new subtype-selective oral histone deacetylase inhibitor, in patients with relapsed or refractory peripheral T-cell lymphoma.JOURNAL OF CLINICAL ONCOLOGY,suppl.S(15).
MLA Shi, Yuan-Kai,et al."Phase II study of chidamide (CS055), a new subtype-selective oral histone deacetylase inhibitor, in patients with relapsed or refractory peripheral T-cell lymphoma".JOURNAL OF CLINICAL ONCOLOGY suppl.S.15(2013).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Shi, Yuan-Kai]的文章
[Dong, Mei]的文章
[Hong, Xiao-Nan]的文章
百度学术
百度学术中相似的文章
[Shi, Yuan-Kai]的文章
[Dong, Mei]的文章
[Hong, Xiao-Nan]的文章
必应学术
必应学术中相似的文章
[Shi, Yuan-Kai]的文章
[Dong, Mei]的文章
[Hong, Xiao-Nan]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。